Identification of an astrocyte cell population from human brain that expresses perforin, a cytotoxic protein implicated in immune defense

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 451-460

  Gasque, Philippe ^a   Jones, Jane ^a   Singhrao, Sim K ^a   Morgan, B Paul ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYTOTOXIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; PERFORIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CELL POPULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEGENERATIVE DISEASE; FETUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; PORE FORMING CYTOTOXIC PROTEINS; RATS; RNA, MESSENGER;

EID: 0032536444     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.451     Document Type: Article

References (28)

1. Podack, E.R., H. Hengartner, and M.G. Lichtenheld. 1991. A central role of perforin in cytolysis? Annu. Rev. Immunol. 9: 129-157.
2. Liu, C.C., C.M. Walsh, and J.D.E. Young. 1995. Perforin: structure and function. Immunol. Today. 16:194-201.
3. Tschopp, J., and K. Hofman. 1996. Cytotoxic T cells: more weapons for new targets? Trends Microbiol. 4:91-94.
4. Kagi, D., B. Lederman, K. Burki, P. Seiler, B. Odermatt, K.J. Olsen, E.R. Podack, R.M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369: 31-37.
5. VandenBroek, M.F., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W.K. Lutz, C.J.M. Melief, R.M. Zinkernael, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781-1790.
6. Shrikant, P., and E.N. Benveniste. 1996. The central nervous system as an immunocompetent organ. Role of glial cells in antigen persentation. J. Immunol. 157:1819-1822.
7. Moregan, B.P., and P. Gasque. 1996. Expression of complement in the brain: role in health and disease. Immunol. Today. 10:461-466.
8. Adams, M.D., A.R. Kerlavage, R.D. Fleischmann, R.A. Fuldner, C.J. Bult, N.H. Lee, E.F. Kirkness, K.G. Weinstock, J.D. Gocayne, O. White, et al. 1995. Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature. 377 (6547 Suppl.):3-174.
9. Gasque, P., P. Chan, M. Fontaine, A. Ischenko, M. Lamacz, O. Gotze, and B.P. Morgan. 1995. Identification and characterization of the complenent C5a anaphylatoxin receptor on human astrocytes. J. Immunol. 155:4882-4889.
10. Gasque, P., S.K. Singhrao, J.W. Neal, O. Gotze, and B.P. Morgan. 1997. Expression of the receptor for complement C5a (CD88) is upregulated on reactive astrocytes, microglia, and endothelial cells in inflamed human central nervous system. Am. J. Pathol. 150:31-41.
11. Gasque, P., A. Ischenko, J. Legoedec, C. Mauger, M.T. Schouft, and M. Fontaine. 1993. Expression of the complement classical pathway by human glioma in culture. J. Biol. Chem. 268:25068-25074.
12. Singhrao, S.K., J.W. Neal, P. Gasque, B.P. Morgan, and J. Newman. 1996. Role of complement in the aetiology of Pick's disease. J. Neuropathol. Exp. Neurol. 55:578-593.
13. Shinkai, Y., M.C. Yoshida, K. Maeda, T. Kobata, K. Maruyama, J. Yodoi, H. Yagita, and K. Okumura. 1989. Molecular cloning and chromosomal assignment of a human perforin (PFP) gene. Immunogenetics 30:452-457.
14. Baetz, K., S. Isaaz, and G.M. Griffiths. 1995. Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J. Immunol. 154:6122-6131.
15. Ojcius, D.M., L.M. Zheng, E.C. Sphicas, A. Zychlinsky, and J.D.E. Young. 1991. Subcellular localization of perforin and serine esterase in lymphokine-activated killer cells and cytotoxic T cells by immunogold labeling. J. Immunol. 146:4427-4432.
16. Hameed, A., K.J. Olsen, L. Cheng, W.M. Fox III., R.H. Hruban, and E.R. Podack. 1992. Immunohistochemical identification of cytotoxic lymphocyte using human perforin monoclonal antibody. Am. J. Pathol. 140:1025-1030.
17. Wucherpfennig, K.W., H.L. Weiner, and D.A. Hafler. 1991. T-cell recognition of myelin basic protein. Immunol. Today. 12:277-282.
18. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G.M. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway. Eur. J. Immunol. 25:1071-1079.
19. Liu, C.C., P.M. Persechini, and J.D.E. Young. 1996. Expression and characterization of functionally active recombinant perforin produced in insect cells. J. Immunol. 156:3292-3300.
20. 2+ changes in individual oligodendrocytes attacked by T-cell perforin. Immunology 74:572-57.
21. Rensing-Ehl, A., U. Malipiero, M. Irmler, J. Tschopp, D. Constam, and A. Fontana. 1996. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (Apo-1/CD95) pathway. Eur. J. Immunol. 26:2271-2274.
22. Dowling, P., G. Shang, S. Raval, J. Menonna, S. Cook, and W. Husar. 1996. Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184;1513-1518.
23. Saas, P., P.R. Walker, M. Hahne, A.L. Quiquerez, V. Schnuriger, G. Perrin, L. French, E.G. VanMeir, N. DeTribolet, J. Tschopp, and P.Y. Dietrich. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J. Clin. Invest. 99:1173-1178.
24. D'Souza, S.D., B. Bonetti, V. Balasingam, N.R. Cashman, P.A. Barker, A.B. Troutt, C.S. Raine, and J.P. Antel. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:2361-2370.
25. Ghatak, N.R. 1992. Occurrence of oligodendrocytes within astrocytes in demyelinating lesions. J. Neuropathol. Exp. Neurol. 51:40-46.
26. Wu, E., C.F. Brosnan, and C.S. Raine. 1993. SP40,40 immunoreactivity in inflammatory CNS lesions displaying astrocyte/oligodendrocyte interactions. J. Neuropathol. Exp. Neurol. 52:129-134.
27. Raine, C.S. 1997. The Norton lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J. Neuroimmunol. 77:135-152.
28. Rogers, C.A., P. Gasque, S.J. Piddlesden, N. Okada, V.M. Holers, and B.P. Morgan. 1996. Expression and function of membrane regulators of complement on rat astrocytes in culture. Immunology 88:153-161.